Ontological Term Details

Compound
FDB022334 (Cer(d18:1/23:0))
Term
Insulin signaling antagonist
Definition
a chemical substance or preparation that interrupts or deminishes insulin signaling, and promotes the opposite biochemical action.
Parent Term
Modulator
Parent Definition
a chemical substance that inhibits or activates a biological or chemical entity or process.
Other Compounds Mapped to 'Insulin signaling antagonist'
  • FDB022245 (N-Palmitoylsphingosine)
  • FDB022334 (Cer(d18:1/23:0))
  • FDB006397 (Ceramide)
  • FDB023536 (Ceramide (d18:1/16:0))
  • FDB023537 (Ceramide (d18:1/18:0))
  • FDB023538 (Ceramide (d18:1/20:0))
  • FDB023539 (Ceramide (d18:1/22:0))
  • FDB023542 (Ceramide (d18:1/26:0))
  • FDB023543 (Ceramide (d18:1/24:0))
  • FDB023544 (Ceramide (d18:1/25:0))

    • References